Κλαύδιος Γαληνός
Δωρεάν εγγραφή Αποκτήσετε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr για έναν μήνα
Έλεγχος συγχορήγησης Ελέγξτε την αγωγή σας για αντενδείξεις και αλληλεπιδράσεις μεταξύ των φαρμάκων
Οι συνταγές μου Αποθηκεύστε τις συνταγές σας και μοιραστείτε τις εύκολα και με ασφάλεια
Μητρότητα και φάρμακα Ενημερωθείτε για την ασφάλεια χορήγησης ενός φαρμάκου κατά τη διάρκεια της εγκυμοσύνης ή του θηλασμού
Συνδρομές Μάθετε περισσότερα για τα οφέλη και τις επιπλέον παροχές των συνδρομητικών προγραμμάτων
Ενδείξεις και αγωγές Βρείτε θεραπευτικές ενδείξεις και αγωγές για νόσους, συμπτώματα και ιατρικές πράξεις
Γνωρίζατε ότι... Μοιραζόμαστε μαζί σας γεγονότα της πορείας του Galinos.gr από το 2011 μέχρι σήμερα

EMERADE Solution for injection in a pre-filled pen (2020)

Αναφορές

Βιβλιογραφική αναφορά

Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

Περιεχόμενα

1. Name of the medicinal product

Emerade 150 micrograms solution for injection in pre-filled pen. Emerade 300 micrograms solution for injection in pre-filled pen. Emerade 500 micrograms solution for injection in pre-filled pen.

2. Qualitative and quantitative composition

The pre-filled pen contains 0.5 ml of adrenaline solution 1 mg/ml. Emerade 150 micrograms delivers a single dose of 0.15 ml containing 150 micrograms of adrenaline (as tartrate). Emerade 300 micrograms ...

3. Pharmaceutical form

Solution for injection in a pre-filled pen (auto-injector). Clear and colourless solution.

4.1. Therapeutic indications

Emerade is indicated for the emergency treatment of severe acute allergic reactions (anaphylaxis) triggered by allergens in foods, medicines, insect stings or bites, and other allergens as well as for ...

4.2. Posology and method of administration

Posology The effective dose is usually within the range 5-10 micrograms per kg bodyweight but higher doses may be necessary in some cases. Paediatric population Use in children: Emerade 500 micrograms ...

4.3. Contraindications

There are no absolute contraindications to the use of Emerade in an allergic emergency.

4.4. Special warnings and precautions for use

Do not remove the needle shield until ready for use. Emerade must be administrated only into the anterolateral thigh. The injection is delivered immediately after the triggering cylinder is pressed against ...

4.5. Interaction with other medicinal products and other forms of interaction

Certain medicines can enhance the effect of adrenaline: Tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and catechol-O-methyl transferase (COMT) inhibitors. Adrenaline must be used with ...

4.6. Pregnancy and lactation

There are no adequate or well-controlled studies of adrenaline during pregnancy. Adrenaline should be used in pregnancy only when the potential benefit to the mother outweighs the possible risk to the ...

4.7. Effects on ability to drive and use machines

Emerade has no or negligible influence on the ability to drive and use machines, however, patients are not recommended to drive or use machines following administration of adrenaline, since they will be ...

4.8. Undesirable effects

Side-effects of adrenaline in general are associated with the α- and β-receptor activity of adrenaline. The following table is based upon experience with the use of adrenaline. The adverse events were ...

4.9. Overdose

An overdose, or an accidental intravascular injection of adrenaline, can originate a sudden increase in blood pressure that can cause cerebral haemorrhage. Severe pulmonary oedema caused by peripheral ...

5.1. Pharmacodynamic properties

<b>Pharmacotherapeutic group:</b> Cardiac stimulants excl. cardiac glycosides Adrenergic and dopaminergic agents – Adrenaline <b>ATC-code:</b> C01CA24 Adrenaline is the natural active sympathomimetic ...

5.2. Pharmacokinetic properties

Circulating adrenaline is metabolized in the liver and other tissues by the enzymes COMT and MAO. Inactive metabolites are excreted in the urine. The half-life of adrenaline in plasma is about 2 to 3 minutes. ...

5.3. Preclinical safety data

Adrenaline has been extensively used in the emergency treatment of severe allergic reactions for many years. There is no further preclinical data relevant for prescribers besides those already described ...

6.1. List of excipients

Sodium chloride Sodium meta-bisulfite (E223) Disodium edetate Hydrochloric acid (for adjustment of pH) Water for injections

6.2. Incompatibilities

In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.

6.3. Shelf life

18 months.

6.4. Special precautions for storage

Store in the original outer carton, however while carrying by patient/carer it is acceptable to store in the specially designed case provided. The pen must always be kept in this case to ensure it is protected. ...

6.5. Nature and contents of container

Emerade consists of a pre-filled syringe made of glass with a polyisoprene rubber needle plunger in an auto-injector. Emerade is latex free. Exposed needle length Emerade 150 micrograms: 16 mm Emerade ...

6.6. Special precautions for disposal and other handling

It is very important that the patient receives detailed information on how to use Emerade. For single use only. The expiry date is indicated on the label and on the outer carton and Emerade should not ...

7. Marketing authorization holder

PharmaSwiss Česká republika s.r.o., Jankovcova 1569/2c, 170 00 Prague 7, Czech Republic

8. Marketing authorization number(s)

Emerade 150 micrograms: PL 33616/0013 Emerade 300 micrograms: PL 33616/0014 Emerade 500 micrograms: PL 33616/0015

9. Date of first authorization / renewal of the authorization

Date of first authorisation: 03 January 2013

10. Date of revision of the text

20 Jan 2020

Πηγαίο έγγραφο

Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:

Μπορείτε να υποστηρίξετε τον Γαληνό στην αποστολή του να παρέχει δωρεάν έγκυρη πληροφόρηση για κάθε φάρμακο απενεργοποιώντας το Ad Blocker για αυτόν τον ιστότοπο.